- Home
- CL vs GSK Comparison
CL vs GSK Comparison
Compare CL & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CL
- GSK
- Stock Information
- Founded
- CL 1806
- GSK 1715
- Country
- CL United States
- GSK United Kingdom
- Employees
- CL N/A
- GSK N/A
- Industry
- CL Package Goods/Cosmetics
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- CL Consumer Discretionary
- GSK Health Care
- Exchange
- CL Nasdaq
- GSK Nasdaq
- Market Cap
- CL 75.4B
- GSK 71.7B
- IPO Year
- CL N/A
- GSK N/A
- Fundamental
- Price
- CL $89.80
- GSK $36.64
- Analyst Decision
- CL Buy
- GSK Hold
- Analyst Count
- CL 19
- GSK 4
- Target Price
- CL $102.22
- GSK $47.00
- AVG Volume (30 Days)
- CL 5.6M
- GSK 5.4M
- Earning Date
- CL 04-25-2025
- GSK 04-30-2025
- Dividend Yield
- CL 2.31%
- GSK 4.36%
- EPS Growth
- CL 12.03
- GSK N/A
- EPS
- CL 3.53
- GSK 0.98
- Revenue
- CL $19,947,000,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- CL $2.98
- GSK $7.19
- Revenue Next Year
- CL $4.09
- GSK $5.34
- P/E Ratio
- CL $25.49
- GSK $18.28
- Revenue Growth
- CL 0.99
- GSK 2.57
- 52 Week Low
- CL $85.32
- GSK $31.72
- 52 Week High
- CL $109.30
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- CL 42.11
- GSK 44.68
- Support Level
- CL $89.98
- GSK $36.42
- Resistance Level
- CL $91.88
- GSK $39.23
- Average True Range (ATR)
- CL 2.00
- GSK 0.76
- MACD
- CL -0.36
- GSK -0.07
- Stochastic Oscillator
- CL 1.44
- GSK 13.02
About CL Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.